Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 8-K Event Regulation FD disclosure · Other events
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 8-K Event Other events
  17. 4 Option exercise Chief Operating Officer acquired 11,153 shares (option exercise)
  18. 424B5 Offering Prospectus
  19. 8-K Event Material agreement · Other events
  20. 424B5 Offering Prospectus

Page 3 of 9 · 162 filings